Sinocera: Adjusting Zirconia Powder Sales Prices Upward from July 27, with a Maximum Increase of 40%

Source: Sinocera's Announcement on Price Adjustment of Zirconia Powder

DentalGoodNews｜On July 20, 2026, Shandong Sinocera Functional Material Co., Ltd. (hereinafter referred to as "Sinocera") announced that, given the continuous rise in the prices of raw and auxiliary materials for Zirconia powder production, and based on recent market conditions and actual circumstances, the company has decided to increase the sales price of Zirconia powder starting July 27, 2026. The price adjustment range is approximately 10% to 40%, subject to the company's official quotation.

According to the announcement, Sinocera stated that it will closely monitor the price trends and supply-demand dynamics of Zirconia powder, and expects that this price increase will have a positive impact on the company's operating performance. As previously reported by DGN (Leading Dental Industry Media, DGN), Sinocera's 2025 financial report showed that its biomedical materials segment achieved revenue of 930 million yuan, a year-on-year increase of 2.11%; the gross profit margin for this segment was 51.21%, down 5.46 percentage points from the same period last year.

Source: Sinocera 2025 Annual Report

Sinocera's biomedical materials business covers products such as nano-grade composite Zirconia powder, Zirconia Block, and Glass-ceramic. Previously, the company had strategically acquired Australian dental materials company SDI Limited. In June 2026, Sinocera announced that it plans to apply through its wholly-owned subsidiary InnoXvest PTY. LTD to China Merchants Bank for a maximum of 600 million yuan in M&A loans and 100 million yuan in hedging credit lines, with the funds specifically used to pay for the transaction consideration, fees, and related costs of acquiring 100% equity of SDI; concurrently, the company will provide a maximum of 700 million yuan in joint and several liability Guarantee for the above debts.

Additionally, Sinocera's board of directors cautioned that the impact of this price increase on sales volume remains uncertain, and the duration of the new sales price cannot be determined, posing a risk of continued price fluctuations.